Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Meng-Hsin Chen

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Journal of Cancer Education : the Official Journal of the American Association for Cancer Education|January 5, 2026
Correction: Evaluating Academic Productivity of Hematology/Oncology FellowsKevin Yang, Umut Akova, Allison Shih, et al.
Langmuir : the ACS Journal of Surfaces and Colloids|February 22, 2014
Hierarchical structure and crystal orientation in poly(ethylene oxide)/clay nanocomposite filmsChe-Yi Chu, Meng-Hsin Chen, Mei-Lin Wu, et al.
Bioorganic & Medicinal Chemistry Letters|November 19, 2010
Synthesis and biological activity of pyridopyridazin-6-one p38 MAP kinase inhibitors. Part 1Robert M Tynebor, Meng-Hsin Chen, Swaminathan R Natarajan, et al.
Bioorganic & Medicinal Chemistry Letters|August 21, 2012
Synthesis and biological activity of pyridopyridazin-6-one p38α MAP kinase inhibitors. Part 2Robert M Tynebor, Meng-Hsin Chen, Swaminathan R Natarajan, et al.
Bioorganic & Medicinal Chemistry Letters|April 10, 2010
Synthesis and biological activity of 2H-quinolizin-2-one based p38alpha MAP kinase inhibitorsRobert M Tynebor, Meng-Hsin Chen, Swaminathan R Natarajan, et al.
Bioorganic & Medicinal Chemistry Letters|March 5, 2008
Synthesis and biological activity of quinolinone and dihydroquinolinone p38 MAP kinase inhibitorsMeng-Hsin Chen, Patricia Fitzgerald, Suresh B Singh, et al.
Bioorganic & Medicinal Chemistry Letters|November 1, 2003
SAR of 3,4-dihydropyrido[3,2-d]pyrimidone p38 inhibitorsLuping Liu, John E Stelmach, Swaminathan R Natarajan, et al.
European Journal of Medicinal Chemistry|March 1, 2020
Discovery of T-1101 tosylate as a first-in-class clinical candidate for Hec1/Nek2 inhibition in cancer therapyShih-Hsien Chuang, Ying-Shuan E Lee, Lynn Y L Huang, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Journal of Cancer Education : the Official Journal of the American Association for Cancer Education|January 5, 2026
Correction: Evaluating Academic Productivity of Hematology/Oncology FellowsKevin Yang, Umut Akova, Allison Shih, et al.
Langmuir : the ACS Journal of Surfaces and Colloids|February 22, 2014
Hierarchical structure and crystal orientation in poly(ethylene oxide)/clay nanocomposite filmsChe-Yi Chu, Meng-Hsin Chen, Mei-Lin Wu, et al.
Bioorganic & Medicinal Chemistry Letters|November 19, 2010
Synthesis and biological activity of pyridopyridazin-6-one p38 MAP kinase inhibitors. Part 1Robert M Tynebor, Meng-Hsin Chen, Swaminathan R Natarajan, et al.
Bioorganic & Medicinal Chemistry Letters|August 21, 2012
Synthesis and biological activity of pyridopyridazin-6-one p38α MAP kinase inhibitors. Part 2Robert M Tynebor, Meng-Hsin Chen, Swaminathan R Natarajan, et al.
Bioorganic & Medicinal Chemistry Letters|April 10, 2010
Synthesis and biological activity of 2H-quinolizin-2-one based p38alpha MAP kinase inhibitorsRobert M Tynebor, Meng-Hsin Chen, Swaminathan R Natarajan, et al.
Bioorganic & Medicinal Chemistry Letters|March 5, 2008
Synthesis and biological activity of quinolinone and dihydroquinolinone p38 MAP kinase inhibitorsMeng-Hsin Chen, Patricia Fitzgerald, Suresh B Singh, et al.
Bioorganic & Medicinal Chemistry Letters|November 1, 2003
SAR of 3,4-dihydropyrido[3,2-d]pyrimidone p38 inhibitorsLuping Liu, John E Stelmach, Swaminathan R Natarajan, et al.
European Journal of Medicinal Chemistry|March 1, 2020
Discovery of T-1101 tosylate as a first-in-class clinical candidate for Hec1/Nek2 inhibition in cancer therapyShih-Hsien Chuang, Ying-Shuan E Lee, Lynn Y L Huang, et al.
Pageof 2